{"id":125,"date":"2019-09-22T17:54:56","date_gmt":"2019-09-22T21:54:56","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/3-17-antiprotozoals\/"},"modified":"2021-12-20T00:52:08","modified_gmt":"2021-12-20T05:52:08","slug":"3-18-antiprotozoals","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/3-18-antiprotozoals\/","title":{"raw":"3.18 Antiprotozoals","rendered":"3.18 Antiprotozoals"},"content":{"raw":"[caption id=\"\" align=\"aligncenter\" width=\"323\"]<img title=\"&quot;Giardia lamblia SEM 8698 lores.jpg&quot; by CDC\/ Janice Haney Carr is licensed under CC0\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2019\/09\/image16.png\" alt=\"Microphoto showing Giardia lamblia\" width=\"323\" height=\"327\" \/> Figure 3.14 Giardia lamblia[\/caption]\r\n\r\nAntiprotozoal drugs target infectious protozoans such as Giardia, an intestinal protozoan parasite that infects humans and other mammals, causing severe diarrhea (see Figure 3.14 for a microscopic image of Giardia). [footnote]<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Giardia_lamblia_SEM_8698_lores.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">\"Giardia lamblia SEM 8698 lores.jpg\"<\/a> by CDC\/ Janice Haney Carr is licensed under <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/cc0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC0<\/a>[\/footnote]\r\n\r\n<strong>Indications:<\/strong>\u00a0 Metronidazole is an example of an antiprotozoal antibacterial medication gel that is commonly used to treat acne rosacea, bacterial vaginosis, or trichomonas. Metronidazole IV is used to treat Giardia and also serious anaerobic bacterial infections such as Clostridium difficile (C-diff).\r\n\r\n<strong>Mechanism of Action:<\/strong> Many antiprotozoal agents work to inhibit protozoan folic acid synthesis, subsequently impairing the protozoal cell.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\r\n\r\n<strong>Special Administration Considerations:<\/strong> It can be administered PO, parenterally, or topically. Orally is the preferred route for GI infections. The nurse should monitor the client carefully for side effects such as seizures, peripheral neuropathies, and dizziness. Psychotic reactions have been reported with alcoholic clients taking disulfiram.\r\n\r\n<strong>Client Teaching &amp; Education<\/strong>\r\n\r\nClients taking antiprotozoal medications should receive education regarding the need for medication compliance and prevention of reinfection.\u00a0 They should be advised that the medication may cause dizziness and dry mouth.\u00a0 Additionally, the medication may cause darkening of the urine.\u00a0 They should also avoid alcoholic beverages during medication therapy to prevent a disulfiram-like reaction.\r\n\r\nIf clients are being treated for protozoal infections such as trichomoniasis, they should be advised that sexual partners might be sources of reinfection even if asymptomatic.\u00a0 Partners should also receive treatment.<sup>[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\r\n\r\nClient teaching should include the avoidance of alcohol during therapy.\r\n<div class=\"textbox textbox--examples\"><header class=\"textbox__header\">\r\n<h2><strong>Clinical Reasoning and Decision-Making Activity 3.17<\/strong><\/h2>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n\r\n<strong>Using the above information, consider the following clinical scenario question:<\/strong>\r\n\r\nA client develops C-diff after taking multiple antibiotics for a non-healing wound. What medication is commonly used to treat C-diff, and what route is used?\r\n\r\nNote: Answers to the activities can be found in the \"<a href=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/chapter-3\/\">Answer Key<\/a>\" sections at the end of the book.\r\n\r\n<\/div>\r\n<\/div>\r\n&nbsp;","rendered":"<figure style=\"width: 323px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" title=\"&quot;Giardia lamblia SEM 8698 lores.jpg&quot; by CDC\/ Janice Haney Carr is licensed under CC0\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2019\/09\/image16.png\" alt=\"Microphoto showing Giardia lamblia\" width=\"323\" height=\"327\" \/><figcaption class=\"wp-caption-text\">Figure 3.14 Giardia lamblia<\/figcaption><\/figure>\n<p>Antiprotozoal drugs target infectious protozoans such as Giardia, an intestinal protozoan parasite that infects humans and other mammals, causing severe diarrhea (see Figure 3.14 for a microscopic image of Giardia). <a class=\"footnote\" title=\"&quot;Giardia lamblia SEM 8698 lores.jpg&quot; by CDC\/ Janice Haney Carr is licensed under CC0\" id=\"return-footnote-125-1\" href=\"#footnote-125-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/p>\n<p><strong>Indications:<\/strong>\u00a0 Metronidazole is an example of an antiprotozoal antibacterial medication gel that is commonly used to treat acne rosacea, bacterial vaginosis, or trichomonas. Metronidazole IV is used to treat Giardia and also serious anaerobic bacterial infections such as Clostridium difficile (C-diff).<\/p>\n<p><strong>Mechanism of Action:<\/strong> Many antiprotozoal agents work to inhibit protozoan folic acid synthesis, subsequently impairing the protozoal cell.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-125-2\" href=\"#footnote-125-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup><\/p>\n<p><strong>Special Administration Considerations:<\/strong> It can be administered PO, parenterally, or topically. Orally is the preferred route for GI infections. The nurse should monitor the client carefully for side effects such as seizures, peripheral neuropathies, and dizziness. Psychotic reactions have been reported with alcoholic clients taking disulfiram.<\/p>\n<p><strong>Client Teaching &amp; Education<\/strong><\/p>\n<p>Clients taking antiprotozoal medications should receive education regarding the need for medication compliance and prevention of reinfection.\u00a0 They should be advised that the medication may cause dizziness and dry mouth.\u00a0 Additionally, the medication may cause darkening of the urine.\u00a0 They should also avoid alcoholic beverages during medication therapy to prevent a disulfiram-like reaction.<\/p>\n<p>If clients are being treated for protozoal infections such as trichomoniasis, they should be advised that sexual partners might be sources of reinfection even if asymptomatic.\u00a0 Partners should also receive treatment.<sup><a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-125-3\" href=\"#footnote-125-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/sup><\/p>\n<p>Client teaching should include the avoidance of alcohol during therapy.<\/p>\n<div class=\"textbox textbox--examples\">\n<header class=\"textbox__header\">\n<h2><strong>Clinical Reasoning and Decision-Making Activity 3.17<\/strong><\/h2>\n<\/header>\n<div class=\"textbox__content\">\n<p><strong>Using the above information, consider the following clinical scenario question:<\/strong><\/p>\n<p>A client develops C-diff after taking multiple antibiotics for a non-healing wound. What medication is commonly used to treat C-diff, and what route is used?<\/p>\n<p>Note: Answers to the activities can be found in the &#8220;<a href=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/chapter-3\/\">Answer Key<\/a>&#8221; sections at the end of the book.<\/p>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-125-1\"><a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Giardia_lamblia_SEM_8698_lores.jpg\" target=\"_blank\" rel=\"noopener noreferrer\">\"Giardia lamblia SEM 8698 lores.jpg\"<\/a> by CDC\/ Janice Haney Carr is licensed under <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/cc0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC0<\/a> <a href=\"#return-footnote-125-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-125-2\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-125-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-125-3\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-125-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":103,"menu_order":18,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":["open-resources-for-nursing-open-rn"],"pb_section_license":""},"chapter-type":[48],"contributor":[68],"license":[],"class_list":["post-125","chapter","type-chapter","status-publish","hentry","chapter-type-numberless","contributor-open-resources-for-nursing-open-rn"],"part":78,"_links":{"self":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/103"}],"version-history":[{"count":3,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/125\/revisions"}],"predecessor-version":[{"id":1892,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/125\/revisions\/1892"}],"part":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/78"}],"metadata":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/125\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=125"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=125"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=125"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}